Page last updated: 2024-10-21

edelfosine and Leukemia P388

edelfosine has been researched along with Leukemia P388 in 2 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marino-Albernas, JR1
Bittman, R1
Peters, A2
Mayhew, E2
Ahmad, I1
Filep, JJ1
Franklin, JC1
Janoff, AS1
Masters, GR1
Pattassery, J1
Schupsky, JJ1
Zha, Y1

Other Studies

2 other studies available for edelfosine and Leukemia P388

ArticleYear
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Journal of medicinal chemistry, 1996, Aug-16, Volume: 39, Issue:17

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Female; Glycosides; Huma

1996
Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Cancer research, 1997, May-15, Volume: 57, Issue:10

    Topics: Animals; Antineoplastic Agents; Ascitic Fluid; Carcinoma, Lewis Lung; Drug Screening Assays, Antitum

1997